| Product Code: ETC7657886 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Organ Transplant Immunosuppressant Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Organ Transplant Immunosuppressant Drugs Market - Industry Life Cycle |
3.4 Israel Organ Transplant Immunosuppressant Drugs Market - Porter's Five Forces |
3.5 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Transplant Type, 2021 & 2031F |
3.7 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Organ Transplant Immunosuppressant Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of organ failure and transplant surgeries in Israel |
4.2.2 Technological advancements in immunosuppressant drugs leading to improved patient outcomes |
4.2.3 Growing healthcare infrastructure and investment in organ transplant procedures in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with immunosuppressant drugs |
4.3.2 Stringent regulatory requirements for approval and usage of immunosuppressant drugs in Israel |
5 Israel Organ Transplant Immunosuppressant Drugs Market Trends |
6 Israel Organ Transplant Immunosuppressant Drugs Market, By Types |
6.1 Israel Organ Transplant Immunosuppressant Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Calcineurin Inhibitors, 2021- 2031F |
6.1.4 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Antiproliferative Agents, 2021- 2031F |
6.1.5 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By mTOR Inhibitor, 2021- 2031F |
6.1.6 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.7 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Antibodies, 2021- 2031F |
6.2 Israel Organ Transplant Immunosuppressant Drugs Market, By Transplant Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Kidney, 2021- 2031F |
6.2.3 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Liver, 2021- 2031F |
6.2.4 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Heart, 2021- 2031F |
6.2.5 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.6 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.7 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Organ Transplant Immunosuppressant Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Organ Transplant Immunosuppressant Drugs Market Import-Export Trade Statistics |
7.1 Israel Organ Transplant Immunosuppressant Drugs Market Export to Major Countries |
7.2 Israel Organ Transplant Immunosuppressant Drugs Market Imports from Major Countries |
8 Israel Organ Transplant Immunosuppressant Drugs Market Key Performance Indicators |
8.1 Average waiting time for organ transplant surgeries in Israel |
8.2 Number of successful organ transplant surgeries performed annually |
8.3 Rate of patient adherence to immunosuppressant drug regimen |
8.4 Percentage of organ transplant patients experiencing rejection episodes |
8.5 Level of government funding allocated to organ transplant procedures in Israel |
9 Israel Organ Transplant Immunosuppressant Drugs Market - Opportunity Assessment |
9.1 Israel Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Transplant Type, 2021 & 2031F |
9.3 Israel Organ Transplant Immunosuppressant Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Organ Transplant Immunosuppressant Drugs Market - Competitive Landscape |
10.1 Israel Organ Transplant Immunosuppressant Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Organ Transplant Immunosuppressant Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here